Nisa Investment Advisors LLC reduced its holdings in shares of Mylan NV (NASDAQ:MYL) by 14.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 82,566 shares of the company’s stock after selling 13,435 shares during the period. Nisa Investment Advisors LLC’s holdings in Mylan were worth $1,572,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of MYL. State of New Jersey Common Pension Fund D boosted its stake in shares of Mylan by 194.0% during the first quarter. State of New Jersey Common Pension Fund D now owns 1,700,000 shares of the company’s stock valued at $48,178,000 after purchasing an additional 1,121,745 shares during the period. Geode Capital Management LLC boosted its stake in shares of Mylan by 15.0% during the fourth quarter. Geode Capital Management LLC now owns 7,875,204 shares of the company’s stock valued at $215,460,000 after purchasing an additional 1,026,731 shares during the period. FIL Ltd boosted its stake in shares of Mylan by 14.1% during the first quarter. FIL Ltd now owns 6,468,868 shares of the company’s stock valued at $183,327,000 after purchasing an additional 799,051 shares during the period. Sector Gamma AS purchased a new stake in shares of Mylan during the first quarter valued at approximately $22,408,000. Finally, State of Tennessee Treasury Department boosted its stake in shares of Mylan by 62.1% during the first quarter. State of Tennessee Treasury Department now owns 1,987,223 shares of the company’s stock valued at $56,317,000 after purchasing an additional 761,160 shares during the period. Institutional investors and hedge funds own 84.03% of the company’s stock.
Mylan stock traded down $0.48 on Friday, hitting $19.84. 6,484,934 shares of the stock traded hands, compared to its average volume of 9,028,671. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.85 and a current ratio of 1.37. The stock has a market capitalization of $10.78 billion, a price-to-earnings ratio of 4.33, a P/E/G ratio of 0.99 and a beta of 1.77. The firm has a fifty day moving average of $18.81. Mylan NV has a 1 year low of $16.63 and a 1 year high of $39.59.
Mylan (NASDAQ:MYL) last announced its quarterly earnings data on Monday, July 29th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.95 by $0.08. The business had revenue of $2.85 billion during the quarter, compared to analyst estimates of $2.82 billion. Mylan had a return on equity of 18.93% and a net margin of 0.30%. The company’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.07 earnings per share. On average, equities analysts forecast that Mylan NV will post 4.27 EPS for the current year.
A number of analysts have recently weighed in on MYL shares. BMO Capital Markets set a $36.00 price objective on Mylan and gave the company a “buy” rating in a research note on Wednesday, May 8th. Raymond James set a $31.00 price objective on Mylan and gave the company a “buy” rating in a research note on Wednesday, May 8th. Citigroup set a $26.00 price objective on Mylan and gave the company a “buy” rating in a research note on Wednesday. BidaskClub raised Mylan from a “sell” rating to a “hold” rating in a research note on Thursday, June 20th. Finally, Zacks Investment Research raised Mylan from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 30th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have given a buy rating to the company’s stock. Mylan has a consensus rating of “Buy” and an average price target of $31.21.
In other news, Director Richard A. Mark acquired 4,000 shares of the stock in a transaction on Wednesday, July 31st. The stock was acquired at an average price of $20.97 per share, with a total value of $83,880.00. Following the completion of the transaction, the director now owns 4,000 shares of the company’s stock, valued at approximately $83,880. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.81% of the company’s stock.
Mylan Company Profile
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS.
See Also: Oversold
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan NV (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.